BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,230,770 | +0.6% | 3,846,154 | 0.0% | 26.28% | -5.5% |
| Q2 2023 | $27,076,924 | -15.6% | 3,846,154 | 0.0% | 27.82% | -37.4% |
| Q1 2023 | $32,076,924 | -27.4% | 3,846,154 | 0.0% | 44.43% | -14.5% |
| Q4 2022 | $44,153,847 | -8.9% | 3,846,154 | 0.0% | 52.00% | +132.2% |
| Q3 2022 | $48,462,000 | +19.1% | 3,846,154 | 0.0% | 22.39% | +39.3% |
| Q2 2022 | $40,692,000 | -34.9% | 3,846,154 | 0.0% | 16.07% | -36.8% |
| Q1 2022 | $62,538,000 | +45.4% | 3,846,154 | 0.0% | 25.44% | +41.3% |
| Q4 2021 | $43,000,000 | – | 3,846,154 | – | 18.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |